Results · Apr-Jun 2026
Thyrocare Technologies Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 24% to ₹240 crore from ₹193 crore in Apr-Jun 2025.
Operating profit grew 34% to ₹77.3 crore, an operating margin of 32.2% (up 2.3 points from a year ago).
Net profit grew 34% to ₹51.3 crore from ₹38.3 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +7%, net profit +5%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 240.0 | 193.0 | +24% |
| Operating profit (EBITDA) | 77.3 | 57.8 | +34% |
| Operating margin | 32.2% | 29.9% | +2.3 pts |
| Net profit | 51.3 | 38.3 | +34% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.